Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8831
|
pubmed:dateCreated |
1992-12-24
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
340
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1350-1
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1360061-Apolipoproteins E,
pubmed-meshheading:1360061-Child,
pubmed-meshheading:1360061-Female,
pubmed-meshheading:1360061-Humans,
pubmed-meshheading:1360061-Hyperlipoproteinemia Type II,
pubmed-meshheading:1360061-Lovastatin,
pubmed-meshheading:1360061-Phenotype,
pubmed-meshheading:1360061-Sex Factors
|
pubmed:year |
1992
|
pubmed:articleTitle |
Apolipoprotein epsilon 4 and coronary artery disease.
|
pubmed:publicationType |
Letter,
Comment
|